Christelle Huguet
President chez ALBIREO PHARMA, INC.
Postes actifs de Christelle Huguet
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALBIREO PHARMA, INC. | President | 02/03/2023 | - |
IPSEN | Directeur Technique/Scientifique/R&D | 22/09/2023 | - |
Ipsen Innovation SASU
Ipsen Innovation SASU Engineering & ConstructionIndustrial Services Part of Ipsen SA, Ipsen Innovation SASU is a French biopharmaceutical company that focuses on improving patients' lives through research and innovation in oncology, rare disease, and neuroscience. Ipsen Innovation is based in Les Ulis, France. The company aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. The company was founded in 1996, and the CEOs are Christelle Huguet and Jose Camara Ferrer. | Directeur Général | 08/07/2021 | - |
Historique de carrière de Christelle Huguet
Anciens postes connus de Christelle Huguet
Sociétés | Poste | Début | Fin |
---|---|---|---|
EPIZYME, INC. | President | 12/08/2022 | - |
Formation de Christelle Huguet
Pasteur Institute | Doctorate Degree |
Statistiques
Internationale
France | 4 |
Etats-Unis | 3 |
Opérationnelle
President | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 4 |
Industrial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
IPSEN | Health Technology |
Entreprise privées | 3 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Ipsen Innovation SASU
Ipsen Innovation SASU Engineering & ConstructionIndustrial Services Part of Ipsen SA, Ipsen Innovation SASU is a French biopharmaceutical company that focuses on improving patients' lives through research and innovation in oncology, rare disease, and neuroscience. Ipsen Innovation is based in Les Ulis, France. The company aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. The company was founded in 1996, and the CEOs are Christelle Huguet and Jose Camara Ferrer. | Industrial Services |
- Bourse
- Insiders
- Christelle Huguet
- Expérience